Title |
Improvements in access to malaria treatment in Tanzania following community, retail sector and health facility interventions -- a user perspective
|
---|---|
Published in |
Malaria Journal, June 2010
|
DOI | 10.1186/1475-2875-9-163 |
Pubmed ID | |
Authors |
Sandra Alba, Angel Dillip, Manuel W Hetzel, Iddy Mayumana, Christopher Mshana, Ahmed Makemba, Mathew Alexander, Brigit Obrist, Alexander Schulze, Flora Kessy, Hassan Mshinda, Christian Lengeler |
Abstract |
The ACCESS programme aims at understanding and improving access to prompt and effective malaria treatment. Between 2004 and 2008 the programme implemented a social marketing campaign for improved treatment-seeking. To improve access to treatment in the private retail sector a new class of outlets known as accredited drug dispensing outlets (ADDO) was created in Tanzania in 2006. Tanzania changed its first-line treatment for malaria from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (ALu) in 2007 and subsidized ALu was made available in both health facilities and ADDOs. The effect of these interventions on understanding and treatment of malaria was studied in rural Tanzania. The data also enabled an investigation of the determinants of access to treatment. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 1% |
South Africa | 2 | 1% |
Colombia | 1 | <1% |
Kenya | 1 | <1% |
Nigeria | 1 | <1% |
United States | 1 | <1% |
Unknown | 157 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 35 | 21% |
Student > Ph. D. Student | 25 | 15% |
Researcher | 20 | 12% |
Student > Doctoral Student | 13 | 8% |
Lecturer | 11 | 7% |
Other | 32 | 19% |
Unknown | 29 | 18% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 30 | 18% |
Social Sciences | 24 | 15% |
Agricultural and Biological Sciences | 21 | 13% |
Nursing and Health Professions | 13 | 8% |
Economics, Econometrics and Finance | 9 | 5% |
Other | 27 | 16% |
Unknown | 41 | 25% |